XML 92 R79.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Non-Vested Stock Options (Details) - USD ($)
6 Months Ended 9 Months Ended
Jun. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Share-based Payment Arrangement, Option, Exercise Price Range        
Granted shares   0 635,643  
Less: Forfeited shares   40,000    
Outstanding shares   1,028,760   1,250,685
Vested Shares   950,759    
Exercisable shares   580,568    
Granted (Weighted-Average Exercise)   $ 0    
Less: Forfeited (Weighted-Average Exercise)   3.46    
Less: Exercised, (Weighted Average Exercise Price)   3.46    
Outstanding (Weight-Average Exercise)   3.83   $ 3.71
Vested (Weighted-Average Exercise)   4.78    
Exercisable (Weighted-Average Exercise)   $ 4.78    
Outstanding Options, weighted average remaining contractual term 7 years 8 months 8 years    
Vested weighted average remaining contractual term   7 years 10 months    
Exercisable weighted average remaining contractual term   7 years 10 months    
Granted Options, Intrinsic Value   $ 0    
Forfeited Options, Intrinsic Value   0    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price   $ 3.05    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period   161,925    
Exercised Options, Intrinsic Value   $ 0    
Outstanding Options, Intrinsic Value   4,140,000   $ 0
Vested Options, Intrinsic value   4,140,000    
Exercisable Options, Intrinsic Value   $ 2,001,000    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 6 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 0.86  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period   20,000